Alpha Teknova, Inc.
TKNONasdaqCIK 1850902HealthcareFiscal year ends Dec 31
Reports and events: 72 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-03-3016:06 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-010926 |
| 2023-03-1516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-008125 |
| 2023-03-1318:43 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-23-007388 |
| 2022-11-1406:31 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-024641 |
| 2022-11-0916:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-023843 |
| 2022-08-1116:09 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016861 |
| 2022-08-1016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-016447 |
| 2022-06-0316:36 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-22-011174 |
| 2022-05-1216:07 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-009650 |
| 2022-05-1116:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-009317 |
| 2022-05-1121:24 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-22-146645 |
| 2022-04-2816:29 ET | DEF 14A | Proxy statementPeriod 2022-06-02 | 0001140361-22-016556 |
| 2022-03-1817:01 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-004176 |
| 2022-03-1516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-076043 |
| 2021-11-1516:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-329872 |
| 2021-11-1206:05 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-004193 |
| 2021-11-1016:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-325979 |
| 2021-08-1306:08 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000950170-21-001408 |
| 2021-08-1116:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-21-243358 |
| 2021-06-2916:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-203268 |
| 2021-06-2106:24 ET | S-1/A | Registration statement, amended | 0001193125-21-194075 |
| 2021-06-0416:14 ET | S-1 | Registration statement | 0001193125-21-182919 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.